It's really good that this is being looked at - so I commend this study by Goldacre - but there is an issue that always gets overlooked with regard to CONSORT, which is that these are "reporting" guidelines, not "conduct" guidelines.
Of course it is important that trials are reported correctly, but if the next step is then not taken, which is to use that report to assess the quality of the trial, then it is useless. It is assumed by some that simply reporting a trial correctly means that you can assume that it has been done correctly. You can't.
And it's not just outcome reporting. It's participant selection, randomisation, adequate controls and/or placebos, adequate blinding, intervention methods, numerous other things before you get anywhere near the analysis on the pre-specified measures.
fwiw, COMPare would not have picked up on PACE, because they didn't switch primary outcome measures with secondary measures, which is what they were looking for here.